4.39
price down icon0.79%   -0.035
after-market Dopo l'orario di chiusura: 4.38 -0.010 -0.23%
loading
Precedente Chiudi:
$4.425
Aprire:
$4.405
Volume 24 ore:
1.22M
Relative Volume:
0.24
Capitalizzazione di mercato:
$1.05B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-14.01
EPS:
-0.3134
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
-4.57%
1M Prestazione:
+20.94%
6M Prestazione:
-20.33%
1 anno Prestazione:
-22.85%
Intervallo 1D:
Value
$4.34
$4.41
Intervallo di 1 settimana:
Value
$4.32
$4.69
Portata 52W:
Value
$3.21
$7.18

Ardelyx Inc Stock (ARDX) Company Profile

Name
Nome
Ardelyx Inc
Name
Telefono
510-745-7047
Name
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Dipendente
395
Name
Cinguettio
@ardelyx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
ARDX's Discussions on Twitter

Confronta ARDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARDX
Ardelyx Inc
4.39 1.06B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-18 Ripresa H.C. Wainwright Buy
2025-05-02 Downgrade Raymond James Strong Buy → Outperform
2025-03-07 Ripresa Ladenburg Thalmann Buy
2025-03-04 Iniziato BTIG Research Buy
2024-11-11 Downgrade H.C. Wainwright Buy → Neutral
2024-07-02 Downgrade Piper Sandler Overweight → Neutral
2024-04-05 Iniziato Leerink Partners Outperform
2023-12-18 Iniziato Raymond James Strong Buy
2023-09-07 Iniziato H.C. Wainwright Buy
2023-08-25 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-03-03 Aggiornamento Wedbush Neutral → Outperform
2022-11-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-05-06 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-12-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2021-10-14 Downgrade Ladenburg Thalmann Buy → Neutral
2021-07-21 Downgrade Jefferies Buy → Hold
2021-07-20 Downgrade Piper Sandler Overweight → Neutral
2021-07-20 Downgrade Wedbush Outperform → Neutral
2021-03-23 Iniziato Wedbush Outperform
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2020-10-20 Ripresa Citigroup Buy
2020-02-18 Ripresa Jefferies Buy
2020-02-12 Iniziato Citigroup Buy
2020-02-10 Iniziato Cowen Outperform
2019-04-08 Iniziato Piper Jaffray Overweight
2018-08-24 Iniziato Jefferies Buy
2018-03-19 Ripresa Leerink Partners Outperform
2017-11-29 Reiterato Citigroup Buy
2017-11-22 Reiterato Ladenburg Thalmann Buy
2017-10-17 Ripresa Leerink Partners Outperform
2016-03-31 Iniziato Ladenburg Thalmann Buy
2016-03-09 Iniziato Cantor Fitzgerald Buy
2016-03-03 Iniziato Citigroup Buy
Mostra tutto

Ardelyx Inc Borsa (ARDX) Ultime notizie

pulisher
Jul 23, 2025

Ardelyx (ARDX) Announced New data for IBSRELA - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Ardelyx Inc. stock priceUnstoppable profit momentum - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Ardelyx Inc. a good long term investmentConsistent triple returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Ardelyx Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025
pulisher
Jul 22, 2025

5 stocks with growth potential: SOUN, JBL, MNTN, ARDX, RCEL - Markets.com

Jul 22, 2025
pulisher
Jul 21, 2025

Ardelyx Announces Q2 2025 Financial Results Conference Call - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

Ardelyx Inc. Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Lobbying Update: $540,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq

Jul 19, 2025
pulisher
Jul 16, 2025

Wedbush Issues Negative Outlook for Ardelyx Earnings - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

This Small-Cap Stock Could 10x By 2030, But It’s Not For The Faint Of Heart - Barchart.com

Jul 15, 2025
pulisher
Jul 15, 2025

Wedbush Raises Price Target on Ardelyx to $13 From $11, Keeps Outperform Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 12, 2025

Long Term Trading Analysis for (ARDX) - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 11, 2025

Jefferies Maintains a Buy Rating on Ardelyx (ARDX) With an $8 Price Target - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Lobbying Update: $50,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative

Jul 11, 2025
pulisher
Jul 11, 2025

There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st

Jul 11, 2025
pulisher
Jul 08, 2025

Ardelyx Faces An Uphill Battle Despite Oral Arguments Set In XPHOZAH Appeal (NASDAQ:ARDX) - Seeking Alpha

Jul 08, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 05, 2025

Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN

Jul 05, 2025
pulisher
Jul 04, 2025

Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT - MSN

Jul 04, 2025
pulisher
Jul 04, 2025

Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 – ARDX - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 03, 2025

Ardelyx amends loan agreement to draw $50 million and secures future options - Investing.com

Jul 03, 2025
pulisher
Jul 02, 2025

Ardelyx spike attributed to Xphozah legal update - MSN

Jul 02, 2025
pulisher
Jul 02, 2025

Ardelyx stock spike attributed to Xphozah update (ARDX:NASDAQ) - Seeking Alpha

Jul 02, 2025
pulisher
Jul 01, 2025

(ARDX) Trading Signals - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jul 01, 2025

A biopharma bolsters patient centricity and trial diversity goals through newly created role - Yahoo Finance

Jul 01, 2025
pulisher
Jun 29, 2025

10 Best Healthcare Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 29, 2025
pulisher
Jun 29, 2025

Two Beaten-Down Biotech Stocks See Big Insider Buys - Barron's

Jun 29, 2025
pulisher
Jun 25, 2025

H.C. Wainwright Initiates Coverage of Ardelyx (ARDX) Stock, Gives Buy - MSN

Jun 25, 2025

Ardelyx Inc Azioni (ARDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):